Variant report

Variant	nsv561866
Chromosome Location	chr13:61328813-61388794
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr13:61361366-61361530	A549	lung:	n/a	n/a
2	CEBPB	chr13:61361279-61361584	HepG2	liver:	n/a	n/a
3	CEBPB	chr13:61364067-61364277	H1-hESC	embryonic stem cell:	n/a	chr13:61364200-61364211
4	CEBPB	chr13:61361259-61361594	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr13:61361169-61361614	ECC-1	luminal epithelium:	n/a	n/a
6	CEBPB	chr13:61365495-61365763	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr13:61369765-61370051	ECC-1	luminal epithelium:	n/a	n/a
8	CEBPB	chr13:61369761-61370052	ECC-1	luminal epithelium:	n/a	n/a
9	CEBPB	chr13:61361158-61361658	ECC-1	luminal epithelium:	n/a	n/a
10	CEBPB	chr13:61361234-61361617	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr13:61329564-61329728	H1-hESC	embryonic stem cell:	n/a	chr13:61329638-61329646
12	CTCF	chr13:61329560-61329710	HMEC	breast:	n/a	chr13:61329638-61329646
13	CTCF	chr13:61329540-61329690	HEEpiC	esophagus:	n/a	chr13:61329638-61329646
14	CTCF	chr13:61329520-61329670	NHEK	skin:	n/a	chr13:61329638-61329646
15	CTCF	chr13:61329580-61329730	HUVEC	blood vessel:	n/a	chr13:61329638-61329646
16	CTCF	chr13:61329480-61329630	MCF-7	breast:	n/a	n/a
17	CTCF	chr13:61329460-61329610	BE2_C	brain:	n/a	n/a
18	CTCF	chr13:61329648-61329691	Pancreas_OC	pancreas:	n/a	n/a
19	CTCF	chr13:61364834-61364895	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr13:61329460-61329610	HMEC	breast:	n/a	n/a
21	CTCF	chr13:61329507-61329742	H1-hESC	embryonic stem cell:	n/a	chr13:61329638-61329646
22	CTCF	chr13:61368620-61368770	GM06990	blood:	n/a	n/a
23	CTCF	chr13:61329560-61329710	Caco-2	colon:	n/a	chr13:61329638-61329646
24	CTCF	chr13:61329543-61329752	HUVEC	blood vessel:	n/a	chr13:61329638-61329646
25	CTCF	chr13:61329560-61329710	HEEpiC	esophagus:	n/a	chr13:61329638-61329646
26	CTCF	chr13:61329579-61329691	A549	lung:	n/a	chr13:61329638-61329646
27	CTCF	chr13:61329560-61329710	HUVEC	blood vessel:	n/a	chr13:61329638-61329646
28	CTCF	chr13:61329606-61329661	GM12878	blood:	n/a	chr13:61329638-61329646
29	CTCF	chr13:61329560-61329710	NHEK	skin:	n/a	chr13:61329638-61329646
30	CTCF	chr13:61374700-61374740	Kidney_OC	kidney:	n/a	n/a
31	CTCF	chr13:61329532-61329768	NHEK	skin:	n/a	chr13:61329638-61329646
32	CTCF	chr13:61329560-61329710	NB4	blood:	n/a	chr13:61329638-61329646
33	CTCF	chr13:61329577-61329726	MCF-7	breast:	n/a	chr13:61329638-61329646
34	CTCF	chr13:61329587-61329674	Kidney_OC	kidney:	n/a	chr13:61329638-61329646
35	CTCF	chr13:61368806-61368827	Hela-S3	cervix:	n/a	n/a
36	CTCF	chr13:61329562-61329684	HepG2	liver:	n/a	chr13:61329638-61329646
37	CTCF	chr13:61329540-61329690	Caco-2	colon:	n/a	chr13:61329638-61329646
38	CTCF	chr13:61329574-61329724	MCF-7	breast:	n/a	chr13:61329638-61329646
39	CTCF	chr13:61329535-61329747	LNCaP	prostate:	n/a	chr13:61329638-61329646
40	CTCF	chr13:61329480-61329630	HRPEpiC	eye:	n/a	n/a
41	CTCF	chr13:61329500-61329650	HEK293	kidney:	n/a	chr13:61329638-61329646
42	CTCF	chr13:61329500-61329650	HCT-116	colon:	n/a	chr13:61329638-61329646
43	CTCF	chr13:61329580-61329730	HAc	cerebellar:	n/a	chr13:61329638-61329646
44	CTCF	chr13:61329540-61329690	SK-N-SH_RA	brain:	n/a	chr13:61329638-61329646
45	CTCF	chr13:61329561-61329738	MCF-7	breast:	n/a	chr13:61329638-61329646
46	CTCF	chr13:61329680-61329830	MCF-7	breast:	n/a	n/a
47	CTCF	chr13:61329560-61329710	HRPEpiC	eye:	n/a	chr13:61329638-61329646
48	CTCF	chr13:61329580-61329730	RPTEC	kidney:	n/a	chr13:61329638-61329646
49	CTCF	chr13:61329540-61329690	Hela-S3	cervix:	n/a	chr13:61329638-61329646
50	CTCF	chr13:61329480-61329630	RPTEC	kidney:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:61330581-61330631	HMEC	breast:	n/a
2	chr13:61330581-61330631	ECC-1	luminal epithelium:	n/a
3	chr13:61330581-61330631	HCPEpiC	choroid plexus:	n/a
4	chr13:61330581-61330631	AG09319	gingival:	n/a
5	chr13:61330581-61330631	SK-N-MC	brain:	n/a
6	chr13:61330581-61330631	HCM	heart:	n/a
7	chr13:61330581-61330631	GM19239	blood:	n/a
8	chr13:61330581-61330631	A549	lung:	n/a
9	chr13:61330581-61330631	T-47D	breast:	n/a
10	chr13:61330581-61330631	ovcar-3	ovarian:	n/a
11	chr13:61330581-61330631	HEK293	kidney:	embryo
12	chr13:61330581-61330631	BJ	skin:	n/a
13	chr13:61330581-61330631	U87	brain:	n/a
14	chr13:61330581-61330631	HNPCEpiC	eye:	n/a
15	chr13:61330581-61330631	HL-60	blood:	n/a
16	chr13:61330581-61330631	NHBE	bronchial:	n/a
17	chr13:61330581-61330631	NHDF-neo	bronchial:	n/a
18	chr13:61330581-61330631	HEEpiC	esophagus:	n/a
19	chr13:61330581-61330631	HPAEpiC	pulmonary alveolar:	n/a
20	chr13:61330581-61330631	K562	blood:	n/a
21	chr13:61330581-61330631	IMR90	lung:	fetal
22	chr13:61330581-61330631	SK-N-SH_RA	brain:	n/a
23	chr13:61330581-61330631	HepG2	liver:	n/a
24	chr13:61330581-61330631	GM12891	blood:	n/a
25	chr13:61330581-61330631	Hela-S3	cervix:	n/a
26	chr13:61330581-61330631	AoSMC	blood vessel:	n/a
27	chr13:61330581-61330631	NH-A	brain:	n/a
28	chr13:61330581-61330631	PANC-1	pancreas:	n/a
29	chr13:61330581-61330631	AG04450	lung:	fetal
30	chr13:61330581-61330631	HIPEpiC	eye:	n/a
31	chr13:61330581-61330631	HRE	kidney:	n/a
32	chr13:61330581-61330631	Hepatocyte	liver:	n/a
33	chr13:61330581-61330631	BE2_C	brain:	n/a
34	chr13:61330581-61330631	HCT-116	colon:	n/a
35	chr13:61330581-61330631	ProgFib	skin:	n/a
36	chr13:61330581-61330631	GM12878	blood:	n/a
37	chr13:61330581-61330631	NT2-D1	testis:	n/a
38	chr13:61330581-61330631	HAEpiC	amniotic membrane:	n/a
39	chr13:61330581-61330631	AG10803	skin:	n/a
40	chr13:61330581-61330631	RPTEC	kidney:	n/a
41	chr13:61330581-61330631	H1-hESC	embryonic stem cell:	embryo
42	chr13:61330581-61330631	HRPEpiC	eye:	n/a
43	chr13:61330581-61330631	PrEC	prostate:	n/a
44	chr13:61330581-61330631	HUVEC	blood vessel:	n/a
45	chr13:61330581-61330631	PFSK-1	brain:	n/a
46	chr13:61330581-61330631	HCF	heart:	n/a
47	chr13:61330581-61330631	HRCEpiC	kidney:	n/a
48	chr13:61330581-61330631	Caco-2	colon:	n/a
49	chr13:61330581-61330631	MCF10A-Er-Src	breast:	n/a
50	chr13:61330581-61330631	GM06990	blood:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:61329166..61329692-chr13:62259510..62260157,2	MCF-7	breast:
2	chr13:61228521..61229179-chr13:61368487..61369171,2	MCF-7	breast:

Variant related genes	Relation type
RNY3P5	TF binding region
RNY3P5	CpG island

Extended variants
information (count: 1287 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:1287 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12874885	chr13:61328813-61328814	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs549728558	chr13:61328817-61328818	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs183631255	chr13:61328851-61328852	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs186792187	chr13:61328863-61328864	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs532107714	chr13:61328870-61328871	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs552225357	chr13:61328874-61328875	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs199866200	chr13:61328900-61328901	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs569158570	chr13:61328905-61328906	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs146199717	chr13:61328940-61328941	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs200159094	chr13:61328944-61328945	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs386771453	chr13:61328945-61328946	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs370495830	chr13:61328946-61328947	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs192094860	chr13:61328970-61328971	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs1514159	chr13:61328990-61328991	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs183464224	chr13:61328998-61328999	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs141246696	chr13:61329042-61329043	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs534589307	chr13:61329047-61329048	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs552438385	chr13:61329095-61329096	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs186653415	chr13:61329107-61329108	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs537962002	chr13:61329142-61329143	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs146950994	chr13:61329143-61329144	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs545044460	chr13:61329151-61329152	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs371880028	chr13:61329158-61329159	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs77980375	chr13:61329159-61329160	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs71199024	chr13:61329200-61329201	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs34582995	chr13:61329201-61329202	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs386379423	chr13:61329210-61329211	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs376836431	chr13:61329218-61329219	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs71095604	chr13:61329219-61329220	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs4886268	chr13:61329231-61329232	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs138500332	chr13:61329252-61329253	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs567965199	chr13:61329258-61329259	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs536944682	chr13:61329286-61329287	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs554165402	chr13:61329298-61329299	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs143980858	chr13:61329303-61329304	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs191358306	chr13:61329304-61329305	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs182382110	chr13:61329312-61329313	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs576098119	chr13:61329325-61329326	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs144414634	chr13:61329342-61329343	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs550242660	chr13:61329343-61329344	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs561889522	chr13:61329359-61329360	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs1514158	chr13:61329369-61329370	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs11616250	chr13:61329397-61329398	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs9538907	chr13:61329415-61329416	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs560175281	chr13:61329420-61329421	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs527601109	chr13:61329423-61329424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs552374463	chr13:61329432-61329433	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs570664200	chr13:61329469-61329470	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs537900576	chr13:61329503-61329504	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs559033343	chr13:61329541-61329542	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Merkel cell carcinoma	19020549	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21858162	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Breast cancer	17393978	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Colorectal cancer	16774939	CNVD
Adenoid cystic carcinoma	17372589	CNVD
abnormal development	18461090	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	16651412	CNVD
Esophageal squamous carcinoma	20200074	CNVD
Myelofibrosis	22110671	CNVD
Anaplastic thyroid cancer	18753363	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:229 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:61326000-61329000	Weak transcription	Fetal Brain Male	brain
2	chr13:61326000-61330200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr13:61326200-61330400	Weak transcription	Fetal Brain Female	brain
4	chr13:61327800-61331600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr13:61328000-61330800	Enhancers	ES-I3 Cell Line	embryonic stem cell
6	chr13:61328000-61330800	Enhancers	iPS-20b Cell Line	embryonic stem cell
7	chr13:61328000-61331000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr13:61328200-61329400	Enhancers	H1 Cell Line	embryonic stem cell
9	chr13:61328200-61330800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr13:61328200-61334400	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr13:61328400-61329000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr13:61328400-61330600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
13	chr13:61328400-61330600	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr13:61328400-61330800	Enhancers	iPS-15b Cell Line	embryonic stem cell
15	chr13:61328400-61331000	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr13:61328600-61329000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
17	chr13:61328600-61329000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
18	chr13:61328600-61329600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr13:61328600-61329800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr13:61328600-61330400	Enhancers	iPS-18 Cell Line	embryonic stem cell
21	chr13:61328800-61329000	Enhancers	Primary hematopoietic stem cells	blood
22	chr13:61328800-61329400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr13:61328800-61329600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr13:61328800-61330000	Weak transcription	H9 Cell Line	embryonic stem cell
25	chr13:61329000-61329400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr13:61329000-61329400	Enhancers	Brain Germinal Matrix	brain
27	chr13:61329000-61330000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
28	chr13:61329000-61330800	Enhancers	Cortex derived primary cultured neurospheres	brain
29	chr13:61329000-61333600	Weak transcription	Primary hematopoietic stem cells	blood
30	chr13:61329000-61334000	Enhancers	Fetal Brain Male	brain
31	chr13:61329200-61329800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr13:61329200-61330600	Enhancers	Fetal Heart	heart
33	chr13:61329200-61331200	Enhancers	Gastric	stomach
34	chr13:61329400-61330400	Weak transcription	H1 Cell Line	embryonic stem cell
35	chr13:61329400-61330400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr13:61329400-61330600	Enhancers	NHEK	skin
37	chr13:61329400-61330800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr13:61329400-61331000	Enhancers	Placenta Amnion	Placenta Amnion
39	chr13:61329400-61331200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr13:61329600-61329800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr13:61329600-61330800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr13:61329600-61332200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr13:61329800-61330200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr13:61329800-61330400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr13:61329800-61330400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
46	chr13:61330000-61330600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
47	chr13:61330000-61330800	Enhancers	H9 Cell Line	embryonic stem cell
48	chr13:61330200-61330800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr13:61330200-61330800	Enhancers	HUVEC	blood vessel
50	chr13:61330200-61334600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links